5-Hydroxy-3,6,7,8,3',4'-hexamethoxyflavone induces apoptosis through reactive oxygen species production, growth arrest and DNA damage-inducible gene 153 expression, and caspase activation in human leukemia cells.

This study examined the growth inhibitory effects of structurally related polymethoxylated flavones in human cancer cells. Here, we report that 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone (5-OH-HxMF) induces growth inhibition of human cancer cells and induction of apoptosis in HL-60 cells through modulation of mitochondrial functions regulated by reactive oxygen species (ROS). ROS generation occurs in the early stages of 5-OH-HxMF-induced apoptosis, preceding cytochrome c release, caspase activation, and DNA fragmentation. The changes occurred after single breaks in DNA were detected, suggesting that 5-OH-HxMF induced irreparable DNA damage, which in turn triggered the process of apoptosis. Up-regulation of Bax was found in 5-OH-HxMF-treated HL-60 cells. In addition, a caspase-independent pathway indicated by endonuclease G also contributed to apoptosis caused by 5-OH-HxMF. Antioxidants suppress 5-OH-HxMF-induced apoptosis. 5-OH-HxMF markedly enhanced growth arrest DNA damage-inducible gene 153 (GADD153) protein in a time-dependent manner. N-acetylcysteine (NAC) and catalase prevented up-regulation of GADD153 expression caused by 5-OH-HxMF. These findings suggest that 5-OH-HxMF creates an oxidative cellular environment that induces DNA damage and GADD153 gene activation, which in turn helps trigger apoptosis in HL-60 cells. Meanwhile, ROS were proven an important inducer in this apoptotic process. The C-5 hydroxyl on the ring of 5-OH-HxMF was found to be essential for the antiproliferative and apoptosis-inducing activity. Our study identified the novel mechanisms of 5-OH-HxMF-induced apoptosis and indicated that these results have significant applications as potential chemopreventive and chemotherapeutic agents.

[1]  Chi-Tang Ho,et al.  Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. , 2006, Journal of agricultural and food chemistry.

[2]  Chi-Tang Ho,et al.  Identification of nobiletin metabolites in mouse urine. , 2006, Molecular nutrition & food research.

[3]  M. Recio,et al.  Anti-inflammatory activity of 5-O-demethylnobiletin, a polymethoxyflavone isolated from Sideritis tragoriganum. , 2006, Planta medica.

[4]  Jen-kun Lin,et al.  Induction of apoptosis by 1-(2-hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione through reactive oxygen species production, GADD153 expression, and caspases activation in human epidermoid carcinoma cells. , 2005, Journal of agricultural and food chemistry.

[5]  D. Bredesen,et al.  Coupling endoplasmic reticulum stress to the cell death program , 2004, Cell Death and Differentiation.

[6]  Xiaodong Wang,et al.  Mitochondrial activation of apoptosis , 2004, Cell.

[7]  M. Gorospe,et al.  Expression of the Pro-apoptotic Genegadd153/chop Is Elevated in Liver with Aging and Sensitizes Cells to Oxidant Injury* , 2003, The Journal of Biological Chemistry.

[8]  H. Tideman,et al.  Upregulation of GADD153 expression in the apoptotic signaling of N‐(4‐hydroxyphenyl)retinamide (4HPR) , 2002, International journal of cancer.

[9]  Jen-kun Lin,et al.  Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. , 2002, Carcinogenesis.

[10]  E V Maytin,et al.  Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. , 2001, Experimental cell research.

[11]  Jen-kun Lin,et al.  Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. , 2001, Journal of agricultural and food chemistry.

[12]  A. Murakami,et al.  Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. , 2000, Cancer research.

[13]  A. Weeraratna,et al.  Thapsigargin induces a calmodulin/calcineurin‐dependent apoptotic cascade responsible for the death of prostatic cancer cells , 2000, The Prostate.

[14]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[15]  S. Lin-Shiau,et al.  Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. , 1999, European journal of pharmacology.

[16]  Y. Tsujimoto,et al.  Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria? , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[17]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[18]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[19]  M. Sporn,et al.  Recent advances in chemoprevention of cancer. , 1997, Science.

[20]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[21]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[22]  G. Kroemer,et al.  Mitochondrial permeability transition is a central coordinating event of apoptosis , 1996, The Journal of experimental medicine.

[23]  Seamus J. Martin,et al.  Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.

[24]  M. Sporn Chemoprevention of cancer. , 1993, Lancet.

[25]  坂平 英樹 Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 2000 .

[26]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[27]  A P Arrigo,et al.  Gene expression and the thiol redox state. , 1999, Free radical biology & medicine.

[28]  A. Meister Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. , 1991, Pharmacology & therapeutics.